Results 191 to 200 of about 11,060,549 (290)

Hereditary Thoracic Aortic Diseases. [PDF]

Diagnostics (Basel)
Spaziani G, Surace FC, Girolami F, Bianco F, Bucciarelli V, Bonanni F, Bennati E, Arcieri L, Favilli S.   +8 more
europepmc   +1 more source

Approach to the Patient with Acute Aortic Syndromes in Light of the New Consensus Statement on Multimodality Imaging in Thoracic Aortic Diseases.

J Cardiovasc Echogr, 2023
Muratori M, Mancini ME, Tamborini G, Mushtaq S, Annoni A, Fusini L, Celeste F, Baggiano A, Fazzari F, Mantegazza V, Pontone G, Pepi M.   +11 more
europepmc   +1 more source

The 24th organ: the aorta. The main concept of new EACTS/STS Guidelines

Heart Vessels and Transplantation
Fabio Massimo Oddi, Grazia Granata, Leonardo Oddi , Giorgio Fedeli, Vincenzo Brizzi   +4 more
doaj   +1 more source

Identification of serum biomarkers and therapeutic targets for aortic diseases in obesity through multi-omics analysis. [PDF]

J Thorac Dis
Wang T, Wang Y, Wang Y, Wang X, Cheng X, Tan Q, Zhu T, Teng X, Huang H, Shen Z.   +9 more
europepmc   +1 more source

A current systematic evaluation and meta‐analysis of chimney graft technology in aortic arch diseases

Journal of Vascular Surgery, 2017
W. Ahmad, S. Mylonas, P. Majd, J. Brunkwall   +3 more
semanticscholar   +1 more source

Lower AKI Risk and Higher Survival With Microaxial Flow Pump Support During Elective PCI: A Propensity Score‐Matched Study

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Acute kidney injury (AKI) is associated with worse outcomes after percutaneous coronary intervention (PCI). Previous, smaller studies suggested nephroprotective effects of micro‐axial flow pump (mAFP) during PCI. This study aimed to compare renal outcomes of high‐risk PCI with mAFP or intraaortic balloon pump (IABP) support.
Elric Zweck, Andrew Shaw, Amin Polzin, Nudrat Noor, Sathya Unudurthi, Michael Cuchiara, Kai M. Schmidt‐Ott, Malte Kelm, Ralf Westenfeld, Rafael Kramann, Ravindra L. Mehta   +10 more
wiley   +1 more source

Exploratory assessment of left ventricular strain–volume loops in severe aortic valve diseases

Journal of Physiology, 2017
H. Hulshof, A. V. van Dijk, K. George, M. Hopman, D. Thijssen, D. Oxborough   +5 more
semanticscholar   +1 more source

Long‐Term Trends in Cardiac Erosion After Transcatheter Closure of Atrial Septal Defects With the Amplatzer Septal Occluder

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Trends in cardiac erosion after closure of secundum atrial septal defects (ASD) with the Amplatzer Septal Occluder (ASO) have not been assessed since updates were made to the Instructions for Use in 2012 and 2018. This study evaluates the incidence and demographics of ASO erosion over time since its introduction in 1996.
Daniel S. Levi, Doff B. McElhinney
wiley   +1 more source

Gut Microbial Taxonomy and Its Role as a Biomarker in Aortic Diseases: A Systematic Review and Future Perspectives. [PDF]

J Clin Med
Neiroukh D, Hajdarpasic A, Ayhan C, Sultan S, Soliman O.   +4 more
europepmc   +1 more source

A Randomized Controlled Trial Comparing the TruSteer and FXD Double Curve Delivery Systems for Left Atrial Appendage Occlusion With the Watchman FLX Pro Device—The GUIDE‐LAAO Study

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Deflectable delivery systems have been introduced to enhance coaxial alignment and procedural efficacy during left atrial appendage occlusion (LAAO), yet randomized comparisons with conventional fixed‐curve systems are lacking. Aims The GUIDE‐LAAO trial evaluated whether the TruSteer deflectable delivery system is non‐inferior to ...
Philippe Taieb, Marco Frazzetto, Pedro Soares Teixeira, Steven J. Filby   +3 more
wiley   +1 more source